These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1855171)

  • 1. Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.
    Soper JT; Berchuck A; Clarke-Pearson DL
    Cancer; 1991 Aug; 68(4):725-9. PubMed ID: 1855171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.
    Soper JT; Berchuck A; Dodge R; Clarke-Pearson DL
    Obstet Gynecol; 1992 Jun; 79(6):993-7. PubMed ID: 1579329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma.
    Piver MS; Lele SB; Bakshi S; Parthasarathy KL; Emrich LJ
    Am J Clin Oncol; 1988 Oct; 11(5):515-9. PubMed ID: 3177251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits.
    Potter ME; Partridge EE; Shingleton HM; Soong SJ; Kim RY; Hatch KD; Austin JM
    Gynecol Oncol; 1989 Mar; 32(3):314-8. PubMed ID: 2920951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging.
    Soper JT; Wilkinson RH; Bandy LC; Clarke-Pearson DL; Creasman WT
    Am J Obstet Gynecol; 1987 May; 156(5):1153-8. PubMed ID: 3578429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer.
    Powell JL; Burrell MO; Kirchner AB
    South Med J; 1987 Dec; 80(12):1513-7. PubMed ID: 3423895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
    Varia MA; Stehman FB; Bundy BN; Benda JA; Clarke-Pearson DL; Alvarez RD; Long HJ;
    J Clin Oncol; 2003 Aug; 21(15):2849-55. PubMed ID: 12885800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer.
    Varia M; Rosenman J; Venkatraman S; Askin F; Fowler W; Walton L; Halle J; Currie J
    Cancer; 1988 Mar; 61(5):919-27. PubMed ID: 3338057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian carcinoma: adjuvant treatment with P-32.
    Reddy S; Sutton GP; Stehman FB; Hornback NB; Ehrlich CE
    Radiology; 1987 Oct; 165(1):275-8. PubMed ID: 3628782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma.
    Soper JT; Creasman WT; Clarke-Pearson DL; Sullivan DC; Vergadoro F; Johnston WW
    Am J Obstet Gynecol; 1985 Sep; 153(2):191-6. PubMed ID: 4037013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer.
    Powell JL; Kirchner AB
    J Med Assoc Ga; 1984 Jan; 73(1):21-5. PubMed ID: 6707541
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant intraperitoneal chromic phosphate therapy in a woman with early ovarian carcinoma and pelvic infection with resulting catastrophic complications.
    McGowan L
    Clin Nucl Med; 1994 Aug; 19(8):696-8. PubMed ID: 7955749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report.
    Klaassen D; Shelley W; Starreveld A; Kirk M; Boyes D; Gerulath A; Levitt M; Fraser R; Carmichael J; Methot Y
    J Clin Oncol; 1988 Aug; 6(8):1254-63. PubMed ID: 3045264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.
    Walton LA; Yadusky A; Rubinstein L
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):939-44. PubMed ID: 2022522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA-125 levels after surgical exploration and radioactive chromic phosphate in ovarian cancer patients.
    Makhija S; Spanos WJ; Day TG; Doering D
    Gynecol Oncol; 1996 Oct; 63(1):85-8. PubMed ID: 8898174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma.
    Wilkinson RH
    J Nucl Med; 1996 Apr; 37(4):636-9. PubMed ID: 8691256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.
    Creasman WT; Disaia PJ; Blessing J; Wilkinson RH; Johnston W; Weed JC
    Am J Obstet Gynecol; 1981 Dec; 141(8):921-9. PubMed ID: 7315922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.
    Young RC; Brady MF; Nieberg RK; Long HJ; Mayer AR; Lentz SS; Hurteau J; Alberts DS
    J Clin Oncol; 2003 Dec; 21(23):4350-5. PubMed ID: 14645424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromic phosphate therapy in carcinoma of the ovary.
    Goodman A; Bornstein L; Ball H; Smith DM; Bankoff M
    J Am Coll Surg; 1994 Oct; 179(4):401-6. PubMed ID: 7921388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary.
    Peters WA; Smith MR; Cain JM; Lee RB; Yon JL
    Gynecol Oncol; 1992 Nov; 47(2):146-9. PubMed ID: 1468691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.